On March 31st, Tania Fleitas and Kirill Veselkov presented an overview of the AIDA project during the second day of the TOGAS kick-off meeting in Riga (Latvia).


AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.

On April 24th, Digestive Cancers Europe (DiCE), a partner of the AIDA consortium, organised the ENTERO Policy Event at the European Parliament. The event brought together policymakers, clinicians, researchers, and patient advocates to highlight a growing concern in Europe: the rise of early-onset digestive cancers, including colorectal and gastric cancer.

On the 24th and 25th of March, the AIDA Consortium gathered in London for the AIDA General Assembly 2025. Hosted by Imperial College London, the two-day meeting brought together leading experts and project partners to discuss the latest advancements in AI-driven gastric cancer research. The assembly commenced with a warm welcome from INCLIVA and Imperial College London, setting the stage
Funded by the European Union under the Horizon Europe Framework Programme Grant Agreement Nº: 101095359. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the European Health and Digital Executive Agency can be held responsible for them.